ID

42817

Descripción

Ropinirole Case Report Form GSK RRL100013 GSK Study ID: 100013 Clinical Study ID: RRL100013 A 12-Week, Double-Blind, Placebo-Controlled, Twice-Daily Dosing Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Requiring Extended Treatment Coverage

Palabras clave

Versiones (4)
  1. 22/2/18 22/2/18 -
  2. 24/2/18 24/2/18 -
  3. 25/2/18 25/2/18 -
  4. 17/9/21 17/9/21 -
Titular de derechos de autor

gsk

Subido en

17 de septiembre de 2021

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Ropinirole Case Report Form GSK RRL100013

Inglés

Serious Adverse Event (SAE)

4 formularios  
Serious Adverse Event (SAE) Section 1
Descripción

Serious Adverse Event (SAE) Section 1

Event
Descripción

Diagnosis Only

Tipo de datos

text

Alias
UMLS CUI [1]
C1519255
Start date
Descripción

Start date

Tipo de datos

date

Unidades de medida
  • Day Month Year
Alias
UMLS CUI [1]
C2697888
Day Month Year
Start time
Descripción

Start time

Tipo de datos

time

Alias
UMLS CUI [1]
C1301880
Outcome
Descripción

Outcome

Tipo de datos

integer

Alias
UMLS CUI [1]
C1705586
End date
Descripción

End date

Tipo de datos

date

Unidades de medida
  • Day Month Year
Alias
UMLS CUI [1]
C0806020
Day Month Year
End time
Descripción

End time

Tipo de datos

time

Alias
UMLS CUI [1]
C1522314
Maximum intensity
Descripción

Maximum intensity

Tipo de datos

text

Alias
UMLS CUI [1]
C1710066
Action Taken with lnvestigational Product
Descripción

Action Taken with lnvestigational Product

Tipo de datos

integer

Alias
UMLS CUI [1]
C1704758
Did the subject withdraw from study as a result of this SAE?
Descripción

Withdrawl

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0422727
Is there a reasonable possibility the SAE may have been caused by the investigational product?
Descripción

Relationship to Investigational product

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0085978
UMLS CUI [1,3]
C1519255
SECTION 2 Seriousness
Descripción

SECTION 2 Seriousness

Seriousness SAE
Descripción

Seriousness (specify reason(s) for considering this a SAE, ttl all that apply

Tipo de datos

integer

Alias
UMLS CUI [1]
C1710056
SECTION 3 Demography Data
Descripción

SECTION 3 Demography Data

Demography Data
Descripción

Demography Data

Tipo de datos

integer

Alias
UMLS CUI [1]
C0011298
Date of birth
Descripción

Date of birth

Tipo de datos

date

Unidades de medida
  • Day Month Year
Alias
UMLS CUI [1]
C0421451
Day Month Year
Sex
Descripción

Sex

Tipo de datos

integer

Alias
UMLS CUI [1]
C0079399
SECTION 4
Descripción

SECTION 4

Investigational Product
Descripción

If lnvestigational Product(s) was Stopped

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0304229
SECTION 5
Descripción

SECTION 5

Possible Causes of SAE
Descripción

Possible Causes of SAE

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C3828190
UMLS CUI [1,2]
C1519255
SECTION 6
Descripción

SECTION 6

Medical Conditions
Descripción

RELEVANT Medical Conditions

Tipo de datos

integer

Alias
UMLS CUI [1]
C0012634
Specify any RELEVANT past or current medical disorders, allergies, surgeries, etc. that can help explain the SAE
Descripción

Medical history

Tipo de datos

text

Alias
UMLS CUI [1]
C0262926
Date of Onset
Descripción

Date of Onset

Tipo de datos

date

Alias
UMLS CUI [1]
C0574845
Condition Present at Time of the SAE?
Descripción

Condition Present at Time of the SAE?

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C1519255
If No, Date of Last Occurrence
Descripción

If No, Date of Last Occurrence

Tipo de datos

date

Alias
UMLS CUI [1,1]
C2745955
UMLS CUI [1,2]
C0011008
SECTION 7
Descripción

SECTION 7

Other RELEVANT Risk Factors
Descripción

provide any family or social history (e.g., smoking, alcohol, diet, drug abuse, occupational hazard) relevant to the SAE)

Tipo de datos

text

Alias
UMLS CUI [1]
C0035648
SECTION 8 RELEVANT Concomitant Medications
Descripción

SECTION 8 RELEVANT Concomitant Medications

Alias
UMLS CUI-1
C1828479
UMLS CUI-2
C2347852
Drug Name
Descripción

Drug Name

Tipo de datos

text

Alias
UMLS CUI [1]
C0013227
Dose
Descripción

Dose

Tipo de datos

integer

Alias
UMLS CUI [1]
C3174092
Unit
Descripción

Unit

Tipo de datos

text

Alias
UMLS CUI [1]
C1519795
Frequency
Descripción

Frequency

Tipo de datos

text

Alias
UMLS CUI [1]
C3476109
Route
Descripción

Route

Tipo de datos

text

Alias
UMLS CUI [1]
C0013153
Taken Prior to Study?
Descripción

Taken Prior to Study?

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2826667
Start Date
Descripción

Start Date

Tipo de datos

date

Alias
UMLS CUI [1]
C0808070
Stop Date
Descripción

Stop Date

Tipo de datos

date

Alias
UMLS CUI [1]
C0806020
Ongoing Medication?
Descripción

Ongoing Medication?

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2826666
Reason for Medication
Descripción

Reason for Medication

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0392360
UMLS CUI [1,2]
C0013227
SECTION 9: Drug Details
Descripción

SECTION 9: Drug Details

Alias
UMLS CUI-1
C0013227
UMLS CUI-2
C1522508
Start Date Investigational Product (from REDUCE study)
Descripción

Start Date Investigational Product

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C0013230
Stop Date Investigational Product (from REDUCE study)
Descripción

Stop Date Investigational Product

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0806020
UMLS CUI [1,2]
C0013230
Start Date Prescription Dutasteride
Descripción

Start Date

Tipo de datos

date

Alias
UMLS CUI [1]
C0808070
Stop Date Prescription Dutasteride
Descripción

Stop Date

Tipo de datos

date

Alias
UMLS CUI [1]
C0806020
SECTION 10: Details of RELEVANT Assessments
Descripción

SECTION 10: Details of RELEVANT Assessments

Alias
UMLS CUI-1
C0220825
Details of Relevant Assessments
Descripción

Provide details of any other tests/procedures which were carried out to diagnose or confirm the SAE e.g., laboratory data with units and normal range.

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1261322
UMLS CUI [1,2]
C1519255
SECTION 11: Narrative Remarks
Descripción

SECTION 11: Narrative Remarks

Investigator's signature
Descripción

Investigator's signature

Tipo de datos

text

Alias
UMLS CUI [1]
C2346576
Investigator's name
Descripción

Investigator's name

Tipo de datos

text

Alias
UMLS CUI [1]
C2826892
Date
Descripción

Date

Tipo de datos

date

Alias
UMLS CUI [1]
C0011008
Narrative Remarks
Descripción

Provide a brief narrative description of the SAE and details of treatment given.

Tipo de datos

text

Volver a la parte superior de la página

Similar models

Serious Adverse Event (SAE)

4 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Serious Adverse Event (SAE) Section 1
Event
Item
Event
text
C1519255 (UMLS CUI [1])
Start date
Item
Start date
date
C2697888 (UMLS CUI [1])
Start time
Item
Start time
time
C1301880 (UMLS CUI [1])
Item
Outcome
integer
C1705586 (UMLS CUI [1])
Outcome
Code List
Outcome
CL Item
Recovered (1)
C2826210 (UMLS CUI-1)
(Comment:en)
CL Item
Recovering (2)
C1709864 (UMLS CUI-1)
(Comment:en)
CL Item
Not resolved (3)
C1709277 (UMLS CUI-1)
(Comment:en)
CL Item
Resolved with sequelae (4)
C1709862 (UMLS CUI-1)
(Comment:en)
CL Item
Fatal (5)
C1302234 (UMLS CUI-1)
(Comment:en)
End date
Item
End date
date
C0806020 (UMLS CUI [1])
End time
Item
End time
time
C1522314 (UMLS CUI [1])
Maximum intensity
Item
Maximum intensity
text
C1710066 (UMLS CUI [1])
Item
Action Taken with lnvestigational Product
integer
C1704758 (UMLS CUI [1])
Action Taken with lnvestigational Product
Code List
Action Taken with lnvestigational Product
CL Item
lnvestigational withdrawn (1)
C2349954 (UMLS CUI-1)
C0008976 (UMLS CUI-2)
(Comment:en)
CL Item
dose reduced (2)
C1707814 (UMLS CUI-1)
(Comment:en)
CL Item
dose increased (3)
C1707810 (UMLS CUI-1)
(Comment:en)
CL Item
dose not changed (4)
C0178602 (UMLS CUI-1)
C0443172 (UMLS CUI-2)
(Comment:en)
CL Item
dose interrupted (5)
C1512900 (UMLS CUI-1)
C0178602 (UMLS CUI-2)
(Comment:en)
CL Item
not applicable (6)
C1272460 (UMLS CUI-1)
(Comment:en)
Withdrawl
Item
Did the subject withdraw from study as a result of this SAE?
boolean
C0422727 (UMLS CUI [1])
Relationship to Investigational product
Item
Is there a reasonable possibility the SAE may have been caused by the investigational product?
boolean
C0304229 (UMLS CUI [1,1])
C0085978 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,3])
Item Group
SECTION 2 Seriousness
Item
Seriousness SAE
integer
C1710056 (UMLS CUI [1])
Seriousness SAE
Code List
Seriousness SAE
CL Item
Results in death (1)
C1320832 (UMLS CUI-1)
(Comment:en)
CL Item
Results in disability/incapacity (2)
C0231170 (UMLS CUI-1)
(Comment:en)
CL Item
Is life-threatening (3)
C1517874 (UMLS CUI-1)
(Comment:en)
CL Item
Requires hospitalisation or prolongation of Congenital anomaly/birth defect (4)
C0019993 (UMLS CUI-1)
(Comment:en)
CL Item
 (5)
(Comment:en)
CL Item
Other, specify _______________________existing hospitalisation (see definition) (6)
C0522473 (UMLS CUI-1)
C3840932 (UMLS CUI-2)
(Comment:en)
CL Item
 (7)
(Comment:en)
Item Group
SECTION 3 Demography Data
Demography Data
Item
Demography Data
integer
C0011298 (UMLS CUI [1])
Date of birth
Item
Date of birth
date
C0421451 (UMLS CUI [1])
Item
Sex
integer
C0079399 (UMLS CUI [1])
Sex
Code List
Sex
CL Item
Male (1)
CL Item
Female (2)
Item Group
SECTION 4
Item
Investigational Product
integer
C1519255 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
If lnvestigational Product(s) was Stopped
Code List
Investigational Product
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown at this time (3)
Item Group
SECTION 5
Item
Possible Causes of SAE
integer
C3828190 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Possible Causes of SAE
Code List
Possible Causes of SAE
CL Item
Disease under study (1)
C0012634 (UMLS CUI-1)
(Comment:en)
CL Item
Concomitant medication (2)
C2347852 (UMLS CUI-1)
(Comment:en)
CL Item
Medical condition (3)
C1699700 (UMLS CUI-1)
(Comment:en)
CL Item
Activity related to study participation (e.g., procedures) (4)
C2348568 (UMLS CUI-1)
(Comment:en)
CL Item
Lack of efficacy (5)
C0235828 (UMLS CUI-1)
(Comment:en)
CL Item
Other, specify ______________________ (6)
C2911685 (UMLS CUI-1)
C1521902 (UMLS CUI-2)
(Comment:en)
CL Item
Withdrawal of investigational product(s) (7)
C2349954 (UMLS CUI-1)
C0013227 (UMLS CUI-2)
(Comment:en)
Item Group
SECTION 6
RELEVANT Medical Conditions
Item
Medical Conditions
integer
C0012634 (UMLS CUI [1])
Medical history
Item
Specify any RELEVANT past or current medical disorders, allergies, surgeries, etc. that can help explain the SAE
text
C0262926 (UMLS CUI [1])
Date of Onset
Item
Date of Onset
date
C0574845 (UMLS CUI [1])
Condition Present at Time of the SAE?
Item
Condition Present at Time of the SAE?
boolean
C0012634 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
If No, Date of Last Occurrence
Item
If No, Date of Last Occurrence
date
C2745955 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item Group
SECTION 7
Other RELEVANT Risk Factors
Item
Other RELEVANT Risk Factors
text
C0035648 (UMLS CUI [1])
Item Group
SECTION 8 RELEVANT Concomitant Medications
C1828479 (UMLS CUI-1)
C2347852 (UMLS CUI-2)
Drug Name
Item
Drug Name
text
C0013227 (UMLS CUI [1])
Dose
Item
Dose
integer
C3174092 (UMLS CUI [1])
Unit
Item
Unit
text
C1519795 (UMLS CUI [1])
Frequency
Item
Frequency
text
C3476109 (UMLS CUI [1])
Route
Item
Route
text
C0013153 (UMLS CUI [1])
Taken Prior to Study?
Item
Taken Prior to Study?
boolean
C2826667 (UMLS CUI [1])
Start Date
Item
Start Date
date
C0808070 (UMLS CUI [1])
Stop Date
Item
Stop Date
date
C0806020 (UMLS CUI [1])
Ongoing Medication?
Item
Ongoing Medication?
boolean
C2826666 (UMLS CUI [1])
Reason for Medication
Item
Reason for Medication
text
C0392360 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
Item Group
SECTION 9: Drug Details
C0013227 (UMLS CUI-1)
C1522508 (UMLS CUI-2)
Start Date Investigational Product
Item
Start Date Investigational Product (from REDUCE study)
date
C0808070 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
Stop Date Investigational Product
Item
Stop Date Investigational Product (from REDUCE study)
date
C0806020 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
Start Date
Item
Start Date Prescription Dutasteride
date
C0808070 (UMLS CUI [1])
Stop Date
Item
Stop Date Prescription Dutasteride
date
C0806020 (UMLS CUI [1])
Item Group
SECTION 10: Details of RELEVANT Assessments
C0220825 (UMLS CUI-1)
Details of Relevant Assessments
Item
Details of Relevant Assessments
text
C1261322 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Item Group
SECTION 11: Narrative Remarks
Investigator's signature
Item
Investigator's signature
text
C2346576 (UMLS CUI [1])
Investigator's name
Item
Investigator's name
text
C2826892 (UMLS CUI [1])
Date
Item
Date
date
C0011008 (UMLS CUI [1])
Narrative Remarks
Item
Narrative Remarks
text
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial